Saxenda

Active Ingredient(s): Liraglutide Recombinant
FDA Approved: * December 23, 2014
Pharm Company: * NOVO NORDISK INC
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Saxenda Overview

Liraglutide, sold under the brand name Victoza among others, is a medication used to treat diabetes mellitus type 2 and obesity.[1] In diabetes it is a less preferred agent.[1][2] Its effects on long term health outcomes like heart disease and life expectancy are unclear.[1] In obesity if after 12 weeks less than 5% of body weight is lost it is recommended the medication be stopped.[3] It is given by injection und...

Read more Saxenda Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Liraglutide

Recent Saxenda Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Liraglutide Recombinant
  • Injection: 6mg/ml
  • Solution: 0.6mg, 18mg/3ml (6mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Saxenda: (1 result)

Sorted by National Drug Code
  • 0169-2800 Saxenda 6 mg/ml Subcutaneous Injection, Solution by Novo Nordisk

Other drugs which contain Liraglutide Recombinant or a similar ingredient: (2 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 August 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA